Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

6.50
+0.03000.46%
Volume:18.23M
Turnover:117.99M
Market Cap:2.61B
PE:-3.84
High:6.72
Open:6.59
Low:6.31
Close:6.47
Loading ...

Company Profile

Company Name:
Recursion Pharmaceuticals, Inc.
Exchange:
NASDAQ
Establishment Date:
2013
Employees:
500
Office Location:
41 South Rio Grande Street,Salt Lake City,Utah,United States
Zip Code:
84101
Fax:
801 821 2872
Introduction:
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 1b/2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer; REC-64151 for the treatment of immune checkpoint resistance; and Anti-PD-(L)1, an orally bioavailable small molecule to improve sensitivity to immune checkpoint inhibitors in non-small cell lung cancer and additional tumors. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Directors

Name
Position
Christopher Gibson
Chief Executive Officer and Director
R. Martin Chavez
Chair of the Board
Blake Borgeson
Director
Dean Li
Director
Robert M. Hershberg
Director
Terry Ann Burrell
Director
Zachary Bogue
Director
Zavain Dar
Director

Shareholders

Name
Position
Christopher Gibson
Chief Executive Officer and Director
Tina Marriott Larson
Chief Operating Officer and President
Michael Secora
Chief Financial Officer
Ramona Doyle
Chief Medical Officer
Shafique Virani
Chief Corporate Development Officer